Mechanism-centric regulatory network identifies NME2 and MYC programs as markers of Enzalutamide resistance in CRPC is a research paper published in Nature Communications (2024). On theSindex it has a DataRank of 0.477. It has been cited 23 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.477
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCI NIH HHS
Grant: R01 CA257258
NLM NIH HHS
Grant: R01 LM013236
NCI NIH HHS
Grant: F30 CA250196
NCI NIH HHS
Grant: P50 CA180995
National Institutes of Health
Grant: 1R01LM013236-01A1
Generalizable biomedical informatics strategies for predictive modeling of treatment response
National Science Foundation
Grant: 2127309
Computing Innovation Fellows Project 2021
National Institutes of Health
Grant: 5F30CA250196-02
Elucidation of a structural rationale for the binding of Myc by small molecule inhibitors
National Institutes of Health
Grant: 5K11HD000790-04
CHARACTERIZATION OF HUMAN LYSOSOMAL ENZYME GENES
National Institutes of Health
Grant: 5P50CA180995-07
SPORE in Prostate Cancer
National Institutes of Health
Grant: 5R01CA257258-04
Small molecule probes of MYC stability and function intumorigenesis
FWCI
6.29
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals